NCT01056263
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site New York, United States